vigil sanofi - Search News

News

Sanofi buys Vigil Neuroscience for $470m

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share

Vigil Neuroscience (VIGL) and Sanofi (SNY) announced that it has entered into a definitive merger agreement pursuant to which Sanofi will acquire Vigil for an upfront payment of $8.00 per share of common stock in cash.

· 3d

· 3d · on MSN

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

· 3d · on MSN

Sanofi to buy Vigil Neuroscience in $470M deal (update)

Fierce Biotech3d

Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

PharmTech2d

Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

Pharmabiz2d

Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million

Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million: Paris Friday, May 23, 2025, 11:00 Hrs [IST] Sanofi, an innovative global healthcare co ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Sanofi buys Vigil Neuroscience for $470m

Trending now